V. Montenegro et al., Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis, J RHEUMATOL, 27(2), 2000, pp. 411-417
Objective. Expression of IgA Fc receptors (CD89, Fc alpha R) and their occu
pancy by endogenous IgA were studied on blood monocytes and neutrophils to
determine if Fc alpha R defects could account for enhanced serum IgA and Ig
A-IC commonly found in patients with ankylosing spondylitis (AS).
Methods. Peripheral blood samples were obtained from 34 patients with AS, 1
5 patients with rheumatoid arthritis, and 34 healthy individuals. Cell surf
ace Fc alpha R was analyzed using a quantitative flow cytometry method in w
hich blood cells were stained with anti-Fc alpha R monoclonal antibodies re
cognizing epitopes outside the IgA binding site and with F(ab')(2) fragment
s of anti-IgA antibodies. Modulation of cell surface Fc alpha R was evaluat
ed after incubation of blood cells at 37 degrees C in absence of plasma. Bi
ochemical characterization of iodinated Fc alpha R molecules was determined
by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel elect
rophoresis (SDS-PAGE).
Results. Fc alpha R expression was significantly decreased on monocytes and
neutrophils in patients with AS compared to control groups, Fc alpha R lev
els were inversely correlated with serum IgA, suggesting its negative regul
atory role. Modulation experiments resulted in rapid and higher Fc alpha R
upregulation in AS than in controls, indicating that these molecules were d
ownregulated only at the cell surface. Moreover, analysis of the surface io
dinated Fc alpha R molecules by SDS-PAGE revealed higher M-r (60-90 kDa) in
AS than controls (55-75 kDa), also suggesting an altered glycosylation. An
alysis of receptor occupancy revealed high levels of endogenous IgA bound t
o monocytes and neutrophils in patients with AS, pointing to a saturation o
f IgA Fc receptors.
Conclusion. We observed impaired expression of Fc alpha R inpatients with A
S that is characterized by a downregulation process associated with post-tr
anslational alterations and enhanced binding of endogenous IgA, These alter
ations might lead to a defective blood clearance by Fc alpha R resulting in
the enhancement of IgA and IgA-IC in AS patients. Decreased Fc alpha R exp
ression represents a new marker for this disease.